Asan Medical Center Achieves Korea’s First 8,000 Kidney Transplants
15-Year Transplanted Kidney Survival Rate at 80.1%
Responsible for 20% of Korea's Kidney Transplants in the Past 5 Years
Asan Medical Center has become the first institution in Korea to achieve 8,000 kidney transplants. The 15-year survival rate for transplanted kidneys reached 80.1%, and the hospital continues to demonstrate excellent long-term outcomes, including a 5-year survival rate of 94.1% even for blood type-incompatible transplants.
On June 1, Asan Medical Center announced that it had achieved Korea's first 8,000 kidney transplants by recently performing a transplant for a patient with chronic renal failure.
Seoul Asan Medical Center's Organ Transplant Center Kidney Transplant Team reached 8,000 kidney transplants on the 20th of last month by transplanting a wife's kidney to a patient with chronic renal failure. The first on the right is Younghoon Kim, Professor of Kidney and Pancreas Transplant Surgery at Seoul Asan Medical Center. Seoul Asan Medical Center
View original imageSince starting deceased donor kidney transplants in 1990, Asan Medical Center has performed a total of 8,000 kidney transplants, including 6,312 living donor kidney transplants and 1,688 deceased donor kidney transplants. In the past five years, the hospital has accounted for one in every five kidney transplants performed nationwide.
The hospital's treatment outcomes remain at a world-class level. The survival rates for transplanted kidneys are 98.5% at 1 year, 95.0% at 5 years, and 88.5% at 10 years. The 15-year survival rate stands at 80.1%. The survival rate for transplanted kidneys refers to the percentage of transplanted kidneys that continue to function normally without the need for re-transplantation or dialysis. The hospital has also shown outstanding results in blood type-incompatible and other immunologically high-risk transplants.
Since succeeding in its first blood type-incompatible kidney transplant in 2009, Asan Medical Center has performed 1,315 such procedures to date, the highest number in Korea. Blood type-incompatible kidney transplants now account for 20.3% of all living donor kidney transplants at the hospital. The 5-year survival rate for transplanted kidneys in these patients is 94.1%, which is comparable to the rate for blood type-compatible transplants (93.5%). Among immunologically high-risk patients, such as those who test positive in crossmatch tests, the 5-year transplanted kidney survival rate is 93.0%, showing little difference from the standard risk group (93.9%).
There has also been a significant increase in kidney transplants for elderly patients. The median age of transplant recipients has risen from 36 years in the 1990s to 52 years from 2020 to 2025. Currently, patients in their 50s make up the largest share at 31.9%, and the proportion of patients aged 60 or older continues to increase.
Asan Medical Center is also actively performing robotic kidney transplants. To date, it has conducted more than 200 robotic kidney transplants—the highest number in Asia—and has achieved treatment outcomes similar to those of open surgery.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Younghoon Kim of the Department of Kidney and Pancreas Transplant Surgery at Asan Medical Center stated, "Achieving the nation's first 8,000 kidney transplants is a result of our multidisciplinary collaborative system. We will continue to strive for the long-term survival and improved quality of life of end-stage renal disease patients, including those who are high-risk or elderly."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.